An educational intervention on prostate cancer in masculine population among 40-60 years
Abstract
Background: prostate cancer is a world sanitary problem of utmost importance, for it constitutes the most common neoplasia in men. Prostate cancer is the second most frequent neoplasia in males for incidence and the fifth by cause of death worldwide. It is estimated that more than 1,1 millions are new cases and about 300 000 deaths take place per year.
Objective: to modify the level of knowledge on prostate cancer.
Methods: an educational intervention was conducted on prostate cancer. The universe of study was composed by 54 patients from 40 to 60 years from clinic 4 in health center Nguyen Van Troi in Guáimaro, from May to July 2015. The sample of 39 patients that was chosen in a non-probabilistic and intentional way among people who consented to participate, an educational intervention organized in three stages was applied. The information was obtained through a questionnaire that was applied before and after the intervention.
Results: it was found that before applying the educational intervention insufficient knowledge on risk factors, clinical manifestations, diagnosis, and preventive measures prevailed.
Conclusions: the educational intervention modified the participants' level of knowledge favorably demonstrating its effectiveness.
DeCS: PROSTATIC NEOPLASMS/prevention & control; RISK FACTORS; CLINICAL TRIAL; MIDDLE AGED; HEALTH EDUCATION.
Downloads
References
1.Cortés Cardona CM, Mejia Luis FF. Caracterización Sociodemográfica y Patológica del Cáncer de Próstata, Hospital Escuela Universitario e Instituto Hondureño Seguridad Social, Tegucigalpa, Honduras. Arch Med Manizales [Internet]. Abr 2017 [citado 26 Dic 2017];13(2):[aprox. 4 p.]. Disponible en: http://www.archivosdemedicina.com/medicina-de-familia/caracterizacioacuten-sociodemograacutefica-y-patoloacutegica-del-caacutencer-de-proacutestata-hospital-escuela-universitario-e-ins.pdf
2.Sagué Larrea Jl, Franco Camejo L, Doimeadios Rodríguez Z. Propuesta de un plan de acción para reducir la mortalidad por cáncer de próstata en Holguín. CCM [Internet]. Mar 2017 [citado 26 May 2017];21(1):[aprox. 8 p]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1560-43812017000100018&lng=es
3.Escalona Veloz R, Estrada Mateo NR. Demostración histoquímica de mucina para el diagnóstico diferencial de las lesiones benignas y malignas de próstata. MEDISAN [Internet]. Abr 2017 [citado 26 May 2017];21(4):[aprox. 7 p]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192017000400002&lng=es
4.Infomed [Internet]. La Habana: Dirección Nacional de Registros Médicos y Estadísticas de Salud Anuario Estadístico de Salud 2015; 2016 [actualizado 12 Mar 2016; citado 16 Jun 2016]. Mortalidad por tumores malignos en el sexo masculino según localización y grupo de edad; [aprox. 2 pantallas]. Disponible en: http://www.sld.cu/sitios/dne/.
5.Ortiz Arrazola GL, Reyes Aguilar A, Grajales Alonso I, Tenahua Quitl I. Identificación de factores de riesgo para cáncer de próstata. Enfer Univ [Internet]. 2013 [citado 15 May 2016];10(1):[aprox. 4 p.]. Disponible en: http://www.scielo.org.mx/pdf/eu/v10n1/v10n1a2.pdf
6.Moyer V. Screening for prostate cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012 Jul 17;157(2):120-132.
7.Rosario D, Lane J, Metcalfe C, Donovan J, Doble A. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012 Jan 9;344:d7894.
8.OraáTabernero N, Cruzado Rodríguez J, Ossola Lentati G, Martínez del Pino N, Sánchez Fuertes M, Martínez Castellanos F. Efectos del tipo de tratamiento y grupo de riesgo en la calidad de vida y la información en pacientes con cáncer de próstata. Psicooncologia [Internet]. Jul 2017 [citado 26 Dic 2017];14(2-3):[aprox. 4 p. ]. Disponible en: revistas.ucm.es/index.php/PSIC/article/download/57083/51519
9.Bacelar Junior AJ, Menezes CS, Barbosa CA, Silva Freitas GB, Gonçalves Silva G, Sousa Vaz JP. Câncer de próstata: métodos de diagnóstico, prevenção e tratamento. BJS [Internet]. 2015 [citado 21 Jun 2016];10(3):[aprox. 6 p.]. Disponible en: http://www.mastereditora.com.br/bjscr/periodico/20150501_174533.pdf
10.Pow Sang M, Huamán M. Retos para el diagnóstico precoz del cáncer de próstata en el Perú. Rev peru med exp salud pública. 2013;30:124-8.
11.Alavanja MC, Bonner MR. Occupational pesticide exposures and cancer risk: a review. J Toxicol Environ Health B Crit Rev. 2012;15(4):238-63.
12.Jurado Penagos A, García Perdomo HA. Efectividad de los micronutrientes en la prevención del cáncer de próstata. Rev Fac Med [Internet]. 2014 [citado 15 May 2016];62(1):[aprox. 7 p.]. Disponible en: http://www.scielo.org.co/pdf/rfmun/v62s1/v62s1a09.pdf
13.Kelly Kandle KK. Conocimientos, actitudes y prácticas de hombres creole del barrio Beholdeen sobre el cáncer de próstata. Bluefields, RACCS - 2014 [tesis]. Bluefields, Nicaragua: Universidad de las Regiones Autónomas de la Costa Caribe Nicaragüense; 2014 [citado 15 May 2016]. Disponible en: http://www.academia.edu/11364220/Conocimientos_actitudes_y_pr%C3%A1cticas_dehombres_creole_del_barrio_Beholdeen_sobre_el_c%C3%A1ncer_de_pr%C3%B3stata.Bluefields_RACCS_2014_
14.Silva João FS, Mattos Inês E, Aydos Ricardo D. Tendência de mortalidade por câncer de próstata nos Estados da Região Centro-Oeste do Brasil, 1980-2011. Rev bras epidemiol [Internet]. 2014 Jun [citado 28 May 2017];17(2):[aprox. 11 p.]. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2014000200395&lng=en
15.Bell N, Gorber SC, Shane A, Joffres M, Singh H, Dickinson J, et al. Recommendations on screening for prostate cancer with the prostate-specific antigen test. Can Med Assoc J. 2014;186(16):1225-1234.
16.Valiente Morejón W, Junco Sena B, Padrón Vega Y, Ramos Águila Y, Castillo García I. Antígeno prostático específico como predictor del diagnóstico de adenocarcinoma prostático. Rev Finlay [Internet]. 2015 [citado 24 Jun 2016];5(4):[aprox. 6 p.]. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/373
17.Cruz Bojórquez RM, González Gallego J, Sánchez Collado P. Propiedades funcionales y beneficios para la salud del licopeno. Nutr Hosp [Internet]. 2013 [citado 21 Jun 2016];28(1):[aprox. 9 p.]. Disponible en: http://www.nutricionhospitalaria.com/pdf/6302.pdf
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025